Genocea Biosciences Company
Genocea Biosciences is a biopharmaceutical company which is engaged in developing novel vaccines and immunotherapies.
Industry:
Atrificial Vectors and Immune Cells
Last Funding Date:
2020-07-22
Investors Number:
13
Last Funding Type:
Post-IPO Equity
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2006-01-01
Funding Status:
IPO
Total Funding:
470569774
Estimated Revenue:
$10M to $50M
Employee Number:
51-100